Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial

Fig. 1

Patient and analysis population flow chart. CE, clinically evaluable. C/T, ceftolozane/tazobactam. ITT, intent-to-treat. ME, microbiologically evaluable. mITT, microbiologic intent-to-treat. N, number of participants in specific analysis population. VABP, ventilator-associated bacterial pneumonia. vHABP, ventilated hospital-acquired pneumonia

Back to article page

Critical Care

ISSN: 1364-8535